PRISCILLA RUSSELL: Open Payments
NPI 1992332027 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 42 payments from 14 companies in 2025. Trend: 2023 $80 · 2024 $1,251 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $161 |
| AstraZeneca Pharmaceuticals LP | 9 | $140 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| Novo Nordisk Inc | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
Products named: TRELEGY ELLIPTA, VRAYLAR, UBRELVY, FARXIGA, QULIPTA, LEQVIO, Cologuard Collection Kit, Wegovy.
Industry payments across SC — which companies pay providers there.
